Melkersson-Rosenthal syndrome

Last revised by Rohit Sharma on 13 Jan 2025

Melkersson-Rosenthal syndrome (MRS), also known as cheilitis granulomatosa or Miescher-Melkersson-Rosenthal syndrome, is a rare condition of unknown etiology characterized by the classic triad of:

The syndrome is rare and typically manifests in young to middle-aged female adults, with a male to female sex ratio of 1:2 5. Pediatric cases have been reported, but are exceptionally rare 5.

The classic triad, as aforementioned, consists of 4,5:

  • recurrent swelling of the face and lips

    • most common symptom

    • typically painless

    • typically unilateral

  • facial nerve (CN VII) paralysis

    • lower motor neuron pattern

    • may be complete or partial, unilateral or bilateral (up to 40% of cases), and transient/recurrent or permanent (less common)

    • involvement of cranial nerves II, VIII, IX and XII have also been reported

  • fissuring or furrowing of the tongue (lingua plicata)

    • may lead to loss of taste, loss of sensation, and tongue infections

    • permanent feature

Although classic, this triad is only seen in up to 25% of cases 4.

The exact aetiopathogensis is not known, but is thought that immunogenic mechanisms play an important role 4,5. In biopsy of an affected lip or part of the face, non-caseating granulomatous cheilitis is seen 5.

Imaging findings are confined to confirming preseptal orbital edema 1. Abnormalities of the facial nerve are not typically seen 1.

Generally, management is typically with short courses of corticosteroids, although a number of other immunosuppressive agents have been trialed in the literature with varying benefit in small series or case reports 5. For facial swelling, intralesional triamcinolone acetonide injections may be helpful 5.

In patients with refractory disease, bony decompression of the facial nerve may help reduce the severity of facial palsy 4,5. Furthermore, reconstructive surgical techniques may be employed for patients with permanent lip swelling 4,5.

The condition was first described, albeit incompletely, by Melkersson in 1928 4. The clinical description was further added to by Rosenthal in 1931 4.

:

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.